An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with numerous of participants share comparison images, injection guides and claims of rapid British shipping. Vendors promote the substance there before redirecting buyers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some experts said the popularity for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.
Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or prison.
Platform Response and Content Elimination
Based on the social media company, the platform has removed problematic material and banned associated keywords and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in enhancing compliance measures.
Digital Trading Operations
Investigations also found communities with up to nine thousand members marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, glowing testimonials and step-by-step guides for preparing or administering at home.
Within minutes of joining one group, a vendor posted contact information, where most transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.
Product Details and Pricing
Inside these communities, posts show black plastic packages with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how much time a pen should last, sellers give contradictory responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service stated it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the increase in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her team has already seen individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to potentially serious health risks”.
